In February, the U.S. Senate bipartisan “Group of Six” released an eagerly anticipated discussion draft bill and a bill summary/request [...] …
Articles by : Ted Slafsky, Publisher & CEO
After reviewing comments from over 250 stakeholders, meeting with various interest groups and holding regular staff meetings, the U.S. Senate [...] …
As we approach the 16-month mark since we had pivotal arguments over the 340B contract pharmacy program in two federal [...] …
Four hospital associations are asking a federal judge in Louisiana to throw out a suit filed by the drug industry [...] …
When I thought about launching 340B Report, the first person I reached out to was Tom Mirga. Tom and I [...] …
Veteran 340B observers were surprised to see that Sen. Bill Cassidy (R-La.) has expanded his 340B investigation into community health [...] …
In what legal experts describe as a landmark decision, the U.S. District Court for the District of South Carolina ruled [...] …
According to our history lessons, George Washington told Thomas Jefferson that the Senate was created to serve as a saucer [...] …
After a recent lull in the ongoing battle over whether drug manufacturers can continue to place restrictions on access to [...] …
Certain flexibilities to the 340B program allowed under the COVID-19 public health emergency will expire May 11 alongside the PHE, the U.S. Health Resources and Services Administration announced Monday.
The update, which HRSA posted prominently on the Office of Pharmacy
…